CCCR News and Updates
11 - 20 of 35
New Treatment Shows Success in High-Risk Solid Tumors
Published on
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
CHOP Researchers Uncover Mechanism that Helps Adenovirus Replicate Efficiently in Host Cells
Published on
In a study published in Nature Microbiology, CHOP researchers uncover a ubiquitination mechanism that helps adenovirus replicate efficiently in host cells.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma
Published on
A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.
Single Cell Technology Zooms In for Clearer View of High-risk Pediatric Cancers
Published on
CHOP researchers were awarded a five-year research grant totaling $12.5 million to create the Center for Pediatric Tumor Cell Atlas as part of a 10-centernational consortium.
CHOP’s Breakthrough Cancer Immunotherapy Program Receives Generous Grant from the Emily Whitehead Foundation
Published on
Emily Whitehead, the first pediatric patient to receive CAR T-cell therapy, and her family honor the CHOP team who saved her life with a $250,000 research grant to expand the use of the therapy for relapsed or refractory ALL.
T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients
Published on
Updated results from a global clinical trial of the CAR T-cell therapy for ALL reveal that children and young adults continued to show high rates of durable, complete remission of their disease.
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
Published on
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
Research on Crucial Cutting Enzyme Maps DNA Damage in Leukemias
Published on
A DNA-cutting enzyme that regulates gene structure has a broad role in causing certain cancers. This discovery may eventually lead to more precise treatments.
Protein Network Signals Found to Drive Myeloid Leukemias
Published on
CHOP researchers reveal how mutations in a protein network drive several high-risk leukemias, offering prospects for new therapies.